Individualized treatment of eating disorders

Neuroendocrinology Letters

Volumn 31, Issue 6, 2010, Pages 754-760

  Ceskova, Eva ^a   Kasparek, Tomas ^a   Dufek, Jan ^a   Valentova, Daria ^a   Palcikova, Ivana ^a   Dockalova, Ruzena ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Anorexia nervosa; Antidepressants; Bulimia nervosa; Guided affective imaginary; Individualized treatment

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SERTRALINE;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY MASS; BULIMIA; CLINICAL FEATURE; CLINICAL TRIAL; FEEDING BEHAVIOR; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALIZED MEDICINE; PROSPECTIVE STUDY; PSYCHOTHERAPY; SYMPTOMATOLOGY; THERAPY EFFECT;

EID: 79751523677     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. American Psychiatric Association: practice guideline for the treatment of patients with eating disorders (revision), work group on eating disorder (2000). Am J Psychiatry 157 (Suppl.): 1-39.
2. Bacaltchuk J, Hay P (2001). Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database Syst Rev 4: CD003391
3. Baranowska B, Wolinska-Witort E, Wasilwska-Dziubinska E, Roguski K, Martynska L, Chmielowska M (2003). The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders. Neuro Endocrinol Lett 24 (6): 431-4. (Pubitemid 38035091)
4. Calandra C, Gulino V, Inserra L, Giuffrida A (1999). The use of Citalopram in an integrated approach to the treatment of eating disorders: an open study. Eat Weight Disord 4 (4): 207-210.
5. Derogatis LR , Lipman RS, Covi L (1973). SCL-90 : an outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull 9 (1): 13-28.
6. Fassino S, Leombruni P, Daga G, Brustolin A, Migliaretti G, Cavallo F, Rovera G (2002). Efficacy of Citalopram in anorexia nervosa: a pilot study. Eur Neuropsychopharmacol 12 (5): 453-459.
7. Garner DM, Olmsted MP, Polivy J (2006). Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord 2 (2): 15-34.
8. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE (1982). The Eating Attitudes Test: psychometric features and clinical correlates. Psychol Med 12 (4): 871-878. (Pubitemid 13174854)
9. Kahn C, Pike K (2001). In search of predictor of dropout from inpatient treatment for anorexia nervosa. Int J Eat Disord 30 (3): 237-244.
10. Kaye WH, Weltzin TE, Hsu LK, Bulik CM (1991). An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 52 (11): 464-471.
11. Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C et al (2001). Double-blind placebo -controlled administration of fluoxetine in restricting and restricting purging type anorexia nervosa. Biol Psychiatry 49 (7): 644-652. (Pubitemid 32289359)
12. Kim SS (2003). Role of fluoxetine in anorexia nervosa. Ann Pharmacother 37 (): 890-892.
13. Kmoch V, Papezova H, Yamamotova A (2009). Two patients with eating disorders treated by Naltrexone. Neuroendocrinol Lett 30 (3): 327-330.
14. Mitchell JE, Agras S, Wonderlich D (2007). Treatment of bulimia nervosa: Where are we and where are we going? Int J Eat Disord 40 (2): 95-101
15. Pallanti S, Quercioli L, Ramacciotti A (1997). Citalopram in anorexia nervosa. Eat Weight Disord 2 (4): 216-221.
16. st ed). In: Raboch J, Anders A, Prasko J, Hellerova P, editors. Psychiatrie. Doporučené postupy psychiatrické péče II. Praha: Infopharm, 2006, p. 127-139.
17. Rybakowski F, Dmitrzak-Weglarz M, Szczepankiewicz A, Skibinska M, Slopien A, Rajewska A, Hauser J (2007). Brain derived neurotrophic factor gene Val66Met and -270C/T polymorphisms and personality traits predisposing to anorexia nervfgosa. Neuro Endocrinol Lett 28 (2): 153-8. (Pubitemid 46739067)
18. Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM (2007). Bulimia nervosa treatment: A systematic review of randomized controlled trials. Int J Eat Disord 40 (4): 321-36. (Pubitemid 46651307)
19. Theiner P, Zackova M (2006). Mirtazapin u mentální anorexie s komorbidní depresí. Psychiat pro Praxi 5: 257-258.
20. Wallis BJ, Lord SM, Barnsley L, Bogduk N (1998). The psychological profiles of the patients with whiplash-associated headache. Cephalgia 18 (2): 101-105. (Pubitemid 28129162)
21. Walsh BT, Kaplan AS, Attia E, Olmsted M, Parides M, Carter JC et al (2006). Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA 295 (22): 2605-12. (Pubitemid 43882335)
22. Wilke E, Leuner H (1990). Das Katathyme Bilderleben in der Psychosomatischen Medizin. Bern, Huber.
23. Yamamotova A, Papezova H, Vevera J (2008). Normalizing effect of bright light therapy on temperature circadian rhythm in patients with eating disorders. Neuro Endocrinol Lett 29 (1): 168-172.
24. Zeeck A, Harmann A, Buchholz C, Herzog T (2005). Dropouts from in-patient treatment of anorexia nervosa. Acta Psychiatr Scand 111 (1): 29-37.